|[June 10, 2014]
Research and Markets: Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/dzrt4d/hematopoietic)
has announced the addition of the "Hematopoietic
Stem Cell Transplantation - Pipeline Review, H1 2014" report to
This report provides comprehensive information on the therapeutic
development for Hematopoietic Stem Cell Transplantation, complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic
development for Hematopoietic Stem Cell Transplantation and special
features on late-stage and discontinued projects.
The report features investigational drugs rom across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from proprietary databases,
Company/University websites, SEC (News - Alert) filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources.
Drug profiles/records featured in the report undergo periodic updating
following a stringent set of processes that ensure all the profiles are
updated with the latest set of information. Additionally, processes
including live news & deals tracking, browser based alert-box and
clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
Celldex Therapeutics, Inc.
Antisense Therapeutics Limited
Actinium Pharmaceuticals, Inc.
Kiadis Pharma B.V.
Bellicum Pharmaceuticals, Inc.
TaiGen Biotechnology Co., Ltd.
Tarix Pharmaceuticals LTD.
For more information visit http://www.researchandmarkets.com/research/dzrt4d/hematopoietic
[ Back To TMCnet.com's Homepage ]